Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Adjuvanted Quadrivalent Influenza Vaccine in Children
NCT01964989Phase 3Completed
- Sponsor
- CSL Seqirus
- Start
- Nov 2013
- Primary completion
- Oct 2015
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 11
01
Overview
A Phase 3 trial of influenza vaccine (surface antigen, inactivated, adjuvanted) in influenza, sponsored by CSL Seqirus. Started Nov 2013; status: completed.
02
Drugs
influenza vaccine (surface antigen, inactivated, adjuvanted)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01964989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01964989.